Cargando…

Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases

Adolescents with underlying diseases are at risk of severe COVID-19. The immune response of BNT162b2 may be poor among immunocompromised adolescents. We aim to describe immunogenicity of mRNA BNT162b2 among adolescents who are immunocompromised or have chronic diseases. We recruited adolescents 12–1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chantasrisawad, Napaporn, Puthanakit, Thanyawee, Tangsathapornpong, Auchara, Techasaensiri, Chonnamet, Phongsamart, Wanatpreeya, Suwanpakdee, Detchvijitr, Jaruampornpan, Peera, Sophonphan, Jiratchaya, Suntarattiwong, Piyarat, Chotpitayasunondh, Tawee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229070/ https://www.ncbi.nlm.nih.gov/pubmed/35746478 http://dx.doi.org/10.3390/vaccines10060871

Ejemplares similares

The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial
por: Chantasrisawad, Napaporn, et al.
Publicado: (2023)

Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster
por: Chantasrisawad, Napaporn, et al.
Publicado: (2022)

Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents
por: Puthanakit, Thanyawee, et al.
Publicado: (2022)

Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study
por: Phongsamart, Wanatpreeya, et al.
Publicado: (2023)

Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance
por: Nantanee, Rapisa, et al.
Publicado: (2023)

Low Measles Seropositivity Rate among Thai Adolescents in the Thai National Immunization Program
por: Puthanakit, Thanyawee, et al.
Publicado: (2022)

Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents
por: Puthanakit, Thanyawee, et al.
Publicado: (2022)

A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
por: Nanthapisal, Sira, et al.
Publicado: (2022)

Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study
por: Techasaensiri, Chonnamet, et al.
Publicado: (2021)

Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac
por: Nantanee, Rapisa, et al.
Publicado: (2022)

Comparing Interferon-Gamma Release Assays to Tuberculin Skin Test in Thai Children with Tuberculosis Exposure
por: Tieu, Hong-Van, et al.
Publicado: (2014)

A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222
por: Nantanee, Rapisa, et al.
Publicado: (2022)

Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers
por: Jantarabenjakul, Watsamon, et al.
Publicado: (2022)

Influenza‐associated hospitalization in urban Thai children
por: Suntarattiwong, Piyarat, et al.
Publicado: (2007)

Immunogenicity of BNT162b2 Vaccination against SARS-CoV-2 Omicron Variant and Attitudes toward a COVID-19 Booster Dose among Healthy Thai Adolescents
por: Assavavongwaikit, Pavinee, et al.
Publicado: (2022)

Clinical outcomes of pediatric COVID-19 in a tertiary care center in Bangkok, Thailand
por: Anugulruengkitt, Suvaporn, et al.
Publicado: (2021)

Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand
por: Aikphaibul, Puneyavee, et al.
Publicado: (2020)

Predictors for influenza vaccination among Thai pregnant woman: The role of physicians in increasing vaccine uptake
por: Kaoiean, Surasak, et al.
Publicado: (2019)

Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi‐centre 48‐week efficacy and safety study in Thailand
por: Phongsamart, Wanatpreeya, et al.
Publicado: (2022)

Influenza vaccination coverage and effectiveness in young children in Thailand, 2011–2013
por: Kittikraisak, Wanitchaya, et al.
Publicado: (2015)

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children
por: Bunupuradah, Torsak, et al.
Publicado: (2015)

Temporal trend of drug-resistant tuberculosis among Thai children during 2006–2021
por: Jantarabenjakul, Watsamon, et al.
Publicado: (2022)

Increased hand washing reduces influenza virus surface contamination in Bangkok households, 2009–2010
por: Levy, Jens W, et al.
Publicado: (2014)

Long COVID and Hybrid Immunity among Children and Adolescents Post-Delta Variant Infection in Thailand
por: Jarupan, Muttharat, et al.
Publicado: (2023)

Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age
por: Kittikraisak, Wanitchaya, et al.
Publicado: (2017)

Knowledge, attitude/perception, and practice related to seasonal influenza vaccination among caregivers of young Thai children: A cross-sectional study
por: Thanee, Chareeya, et al.
Publicado: (2021)

Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency
por: Bunupuradah, Torsak, et al.
Publicado: (2012)

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
por: Chayachinda, Chenchit, et al.
Publicado: (2023)

Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
por: Asavapiriyanont, Suvanna, et al.
Publicado: (2018)

Standardization and Evaluation of an Anti-ZIKV IgM ELISA Assay for the Serological Diagnosis of Zika Virus Infection
por: Sirikajornpan, Kanittha, et al.
Publicado: (2021)

Comparison of incidence and cost of influenza between healthy and high-risk children <60 months old in Thailand, 2011-2015
por: Kittikraisak, Wanitchaya, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy
por: Sudjaritruk, Tavitiya, et al.
Publicado: (2019)

Dengue amid COVID-19 pandemic
por: Tangsathapornpong, Auchara, et al.
Publicado: (2023)

Low risk of neurodevelopmental impairment among perinatally acquired HIV‐infected preschool children who received early antiretroviral treatment in Thailand
por: Jantarabenjakul, Watsamon, et al.
Publicado: (2019)

High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
por: Puthanakit, Thanyawee, et al.
Publicado: (2012)

A Comparison of Cefditoren Pivoxil 8-12 mg/kg/day and Cefditoren Pivoxil 16-20 mg/kg/day in Treatment of Children With Acute Presumed Bacterial Rhinosinusitis: A Prospective, Randomized, Investigator-Blinded, Parallel-Group Study
por: Poachanukoon, Orapan, et al.
Publicado: (2015)

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
por: Bauernfeind, Stilla, et al.
Publicado: (2021)

Typhoidal Salmonella Trends in Thailand
por: Techasaensiri, Chonnamet, et al.
Publicado: (2018)

Analysis of Ganciclovir-Resistant Cytomegalovirus Infection Caused by the UL97 Gene Mutation in Codons 460 and 520 in Pediatric Patients: A Case Series
por: Boonsathorn, Sophida, et al.
Publicado: (2019)

Prevalence, risk factors, and vaccine effectiveness of COVID-19 infection in thai children, adolescents, and young adults in the omicron era
por: Chaiyakulsil, Chanapai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_81kv6331so7v1vr3v61hdhicjv